- Home
- NIC vs HRMY Comparison
NIC vs HRMY Comparison
Compare NIC & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIC
- HRMY
- Stock Information
- Founded
- NIC 2000
- HRMY 2017
- Country
- NIC United States
- HRMY United States
- Employees
- NIC N/A
- HRMY N/A
- Industry
- NIC Major Banks
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- NIC Finance
- HRMY Health Care
- Exchange
- NIC Nasdaq
- HRMY Nasdaq
- Market Cap
- NIC 1.8B
- HRMY 2.0B
- IPO Year
- NIC N/A
- HRMY 2020
- Fundamental
- Price
- NIC $116.70
- HRMY $31.89
- Analyst Decision
- NIC Buy
- HRMY Strong Buy
- Analyst Count
- NIC 4
- HRMY 9
- Target Price
- NIC $119.25
- HRMY $54.22
- AVG Volume (30 Days)
- NIC 59.9K
- HRMY 611.9K
- Earning Date
- NIC 07-15-2025
- HRMY 08-05-2025
- Dividend Yield
- NIC 1.09%
- HRMY N/A
- EPS Growth
- NIC 28.66
- HRMY 13.13
- EPS
- NIC 8.31
- HRMY 2.62
- Revenue
- NIC $352,932,000.00
- HRMY $744,852,000.00
- Revenue This Year
- NIC N/A
- HRMY $20.10
- Revenue Next Year
- NIC $4.08
- HRMY $18.01
- P/E Ratio
- NIC $14.16
- HRMY $12.17
- Revenue Growth
- NIC 9.54
- HRMY 20.62
- 52 Week Low
- NIC $77.49
- HRMY $26.47
- 52 Week High
- NIC $125.50
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- NIC 42.54
- HRMY 36.85
- Support Level
- NIC $115.57
- HRMY $32.39
- Resistance Level
- NIC $118.58
- HRMY $33.42
- Average True Range (ATR)
- NIC 2.11
- HRMY 1.06
- MACD
- NIC -0.55
- HRMY -0.47
- Stochastic Oscillator
- NIC 16.97
- HRMY 6.91
About NIC Nicolet Bankshares Inc.
Nicolet Bankshares Inc is a United States-based bank holding company's principal business is banking, consisting of lending and deposit gathering, as well as ancillary banking-related products and services, to businesses and individuals of the communities it serves, and the operational support to deliver, fund and manage. It offers a variety of loans, deposits, and related services to business customers especially small and medium-sized businesses and professional concerns, business deposit products, cash management services, international banking services, business loans, lines of credit, commercial real estate financing, construction loans, agricultural real estate or production loans, and letters of credit, as well as retirement plan services.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.